These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33740842)

  • 21. Influences of cytochrome b5 expression and its genetic variant on the activity of CYP2C9, CYP2C19 and CYP3A4.
    Yoo SE; Yi M; Kim WY; Cho SA; Lee SS; Lee SJ; Shin JG
    Drug Metab Pharmacokinet; 2019 Jun; 34(3):201-208. PubMed ID: 30992242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine.
    Green B; Crauwels H; Kakuda TN; Vanveggel S; Brochot A
    Clin Pharmacokinet; 2017 May; 56(5):525-536. PubMed ID: 27665573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.
    Dorji PW; Wangchuk S; Boonprasert K; Tarasuk M; Na-Bangchang K
    Drug Metab Pers Ther; 2019 Dec; 34(4):. PubMed ID: 32004143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Similar substrate specificity of cynomolgus monkey cytochrome P450 2C19 to reported human P450 2C counterpart enzymes by evaluation of 89 drug clearances.
    Hosaka S; Murayama N; Satsukawa M; Uehara S; Shimizu M; Iwasaki K; Iwano S; Uno Y; Yamazaki H
    Biopharm Drug Dispos; 2015 Dec; 36(9):636-43. PubMed ID: 26348733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric cannabinoid hyperemesis: two cases.
    Miller JB; Walsh M; Patel PA; Rogan M; Arnold C; Maloney M; Donnino M
    Pediatr Emerg Care; 2010 Dec; 26(12):919-20. PubMed ID: 21131803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inter-phenotypic differences in CYP2C9 and CYP2C19 metabolism: Bayesian meta-regression of human population variability in kinetics and application in chemical risk assessment.
    Quignot N; Więcek W; Lautz L; Dorne JL; Amzal B
    Toxicol Lett; 2021 Feb; 337():111-120. PubMed ID: 33232775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenytoin intoxication associated with omeprazole administration in a child with defective CYP2C9.
    Marano M; Nicoletti F; Pro S; Goffredo BM; Cecchetti C; Piervincenzi E; Agolini E; Cocciadiferro D
    Eur J Clin Pharmacol; 2020 May; 76(5):731-732. PubMed ID: 31938857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, and ABCB1.
    Powers JL; Buys SS; Fletcher D; Melis R; Johnson-Davis KL; Lyon E; Malmberg EM; McMillin GA
    J Clin Pharmacol; 2016 Dec; 56(12):1570-1581. PubMed ID: 27198207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP2C9 and CYP2C19 Allele and Haplotype Distributions in Four Mestizo Populations from Western Mexico: An Interethnic Comparative Study.
    Saldaña-Cruz AM; León-Moreno LC; Sánchez-Corona J; Santiago DA; Mendoza-Carrera F; Castro-Martínez XH; García-Zapién AG; Morán-Moguel MC; Flores-Martínez SE
    Genet Test Mol Biomarkers; 2016 Nov; 20(11):702-709. PubMed ID: 27617498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cannabis hyperemesis syndrome].
    Bonnet U; Chang DI; Scherbaum N
    Fortschr Neurol Psychiatr; 2012 Feb; 80(2):98-101. PubMed ID: 21692016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linkage disequilibrium between the CYP2C19*2,*17 and CYP2C9*1 alleles and impact of VKORC1, CYP2C9, CYP2C19 gene polymorphisms and gene-gene interactions on warfarin therapy.
    Khalighi K; Cheng G; Mirabbasi S; Khalighi B; Wu Y; Fan W
    J Thromb Thrombolysis; 2017 Jan; 43(1):124-129. PubMed ID: 27743182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States.
    Soriano-Co M; Batke M; Cappell MS
    Dig Dis Sci; 2010 Nov; 55(11):3113-9. PubMed ID: 20130993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetic prediction of individual variability in drug response based on CYP2D6, CYP2C9 and CYP2C19 genetic polymorphisms.
    Chaudhry SR; Muhammad S; Eidens M; Klemm M; Khan D; Efferth T; Weisshaar MP
    Curr Drug Metab; 2014; 15(7):711-8. PubMed ID: 25429673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochrome P450 1A1, 2C9, 2C19, and 3A4 Polymorphisms Account for Interindividual Variability of Toxicological Drug Metabolism in Cynomolgus Macaques.
    Uno Y; Uehara S; Murayama N; Yamazaki H
    Chem Res Toxicol; 2018 Dec; 31(12):1373-1381. PubMed ID: 30412386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cannabinoid-induced hyperemesis].
    Lieb M; Palm U; Nicolaus M; Reibke R; Baghai TC
    Psychiatr Prax; 2011 Apr; 38(3):147-9. PubMed ID: 21462097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reply to Letter "Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome".
    Senderovich H; Patel P; Jimenez Lopez B; Waicus S
    Med Princ Pract; 2022; 31(5):499-500. PubMed ID: 35817006
    [No Abstract]   [Full Text] [Related]  

  • 37. Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse.
    Sontineni SP; Chaudhary S; Sontineni V; Lanspa SJ
    World J Gastroenterol; 2009 Mar; 15(10):1264-6. PubMed ID: 19291829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study.
    Pélissier F; Claudet I; Gandia-Mailly P; Benyamina A; Franchitto N
    J Emerg Med; 2016 Nov; 51(5):544-551. PubMed ID: 27485997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid hyperemesis syndrome: a guide for the practising clinician.
    Bajgoric S; Samra K; Chandrapalan S; Gautam N
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26698198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.
    Venkatesan T; Levinthal DJ; Li BUK; Tarbell SE; Adams KA; Issenman RM; Sarosiek I; Jaradeh SS; Sharaf RN; Sultan S; Stave CD; Monte AA; Hasler WL
    Neurogastroenterol Motil; 2019 Jun; 31 Suppl 2(Suppl 2):e13606. PubMed ID: 31241817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.